The brilliant bon vivant and American writer Jim Harrison claimed that man was not put on this earth to consume small portions. But then again, Jim did not stick around long enough to experience Ozempic.
Because, as the past six weeks of personal experience has shown, Ozempic plays God, having turned my once ravenous following of the Jim Harrison doctrine into one whose appetite for food and drink has taken on monistic proportions – although the donning of a sack-cloth habit and the urge to embark on the inspired chanting of hymns has yet to take shape.
But man, if a weekly jab of Ozempic can make me drive past Peregrine Farm Stall in Elgin without even thinking of pulling over for a pepper-steak pie, anything is possible.
Cutting to the chase, Ozempic – like other GLP-1 drugs such as Mounjaro – suppresses the desire to consume food and drink. That is just simply it. You eat and drink less. Not only does one feel sated after a few bites or sips, but the dopamine hit attached to the primal senses being bombarded by a slice of pizza Napoletana with added chilli or a long, cool glug of buttery Chardonnay disappears.

The long-term effects are, hopefully, the lowering of blood sugar and cholesterol as well as shedding a few kilograms. Ozempic, thus, is not rocket science. No banting, seawater enemas, Mediterranean dieting, 18-hour fasts or – heaven forbid – veganism. It just makes you do what your mum or Grandma always told you were the tricks to eating healthy, and that is to eat less.
This it does. As well as, and here the subject of wine comes in, limiting your urge to drink. Not only wine or other alcohol, by the way. Because of the constant sated feeling the drugs cause, downing my recommended two litres of water has become a slog, one akin to what a foie gras goose must experience thrice daily. I am also not washing down snacks of nuts and dry fruit with a pint of milk in the late-afternoon, as the desire for snacks of any kind has gone walkabout, drifting somewhere in outer space, hoping for its master to retrieve his hunger and lust for internal sensorial gratification.
So, if millions of wine-loving Ozempic and Mounjaro users are – like me – drinking less, I’ll go out on the shrinking limb and state that GLP-1s must be a reason why alcohol consumption is tanking worldwide. This insightful observation was vindicated recently while doing a wine-tasting for a bunch of Texans, with seven of the 20 admitting to jabbing GLP-1s and subsequently experiencing a decline in their consumption of Napa Valley Cabernet, Cognac and – as the lady from Houston said – “even fucking goddamn Dom Perignon!”

In my case, it started about a day after my first Ozempic needle, six weeks back. The initial experience was slight indigestion, with the feeling of having a wind sitting in your stomach making the body just feel, well, full and slightly bloated from the inside. Despite forcing down a can of baked beans, the wind was not expelled from any of the body’s two orifices normally reserved for such occasions, hanging around for about three days and making me feel constantly full. For the first time since my days of bland school-dinners in grey English afternoons, with the teachers watching your plate, I had to force myself to eat. Glasses of wine poured from habit, were half-emptied or – as the case on one depressing Tuesday evening – left untouched.
This was truly weird, as not only was I lacking any desire to eat, but the usual interest in the topic of food had vacated the body and soul. Not even a YouTube video of Nigella Lawson nibbling on a whole cylinder of cannelloni pasta could evoke a sense of culinary lust.
Things got better on the fourth day after the first Ozempic hit. At lunch at a sushi joint, I attacked the first sashimi and nigiri pieces with the usual gusto, but after five pieces the chopsticks were put down leaving the rest of the 16-piece sushi special in undisturbed peace, bright and colourful. I finished the glass of Sauvignon Blanc, refusing the refill and causing my usual waitress, Usurpia, to stare at me with a look veering between shock and worry.
Accordingly, the rhythm of the domestic evenings has changed. Dinners are cooked in copious amounts, but one helping of a modest portion is enough for me. In pre-Ozempic days, a languidly consumed large plate of osso buco followed by another smaller second helping and some baguette to mop-up the meaty sauces, would require at least three glasses of Cabernet Sauvignon to accompany the gusto of pleasurable eating.

Now, a single glass at dinner is ample, followed – maybe – by another while ensuring the Ozempic pen has been but back into the fridge and uncoiling your blood-pressure monitor.
While bottles were opened and emptied on a nightly basis, half-empty vessels are now recorked and placed in the refrigerator for later use.
Fortunately, the lesser volume of consumption has not interfered with the enjoyment of wine. In fact, my scientifically unsubstantiated yet personally experienced observation is that Ozempic has heightened my sensorial abilities. Like a Master of Wine candidate or a contributor to Platter’s Guide, I am able to detect layers of aromatic and flavour complexities in wines that I did not know existed. I can grasp onto the slightest hint of a sorrel sharpness in a Chablis, uncoil it from the rest of the flavours and ponder on this persuasive element’s meaning to the wine.
A glass of Médoc is not glugged down with a mouthful of rib-eye. Now it is examined, each component unpacked to stand before me screaming for identification and affirmation of grape and place, requests I honour in words, dreams and letters.
Portions may whither, but the appetite stays the same.























